1. Home
  2. TECX vs ELA Comparison

TECX vs ELA Comparison

Compare TECX & ELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.27

Market Cap

554.1M

Sector

N/A

ML Signal

HOLD

Logo Envela Corporation

ELA

Envela Corporation

HOLD

Current Price

$18.01

Market Cap

449.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
ELA
Founded
2019
1965
Country
United States
United States
Employees
60
N/A
Industry
Consumer Specialties
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
554.1M
449.7M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
TECX
ELA
Price
$29.27
$18.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$75.20
$16.50
AVG Volume (30 Days)
189.7K
56.4K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
115.38
EPS
N/A
0.56
Revenue
N/A
$241,021,362.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$22.54
P/E Ratio
N/A
$31.61
Revenue Growth
N/A
33.62
52 Week Low
$14.39
$5.33
52 Week High
$35.99
$18.98

Technical Indicators

Market Signals
Indicator
TECX
ELA
Relative Strength Index (RSI) 50.66 57.85
Support Level $28.31 $16.09
Resistance Level $31.88 $18.64
Average True Range (ATR) 1.53 0.80
MACD -0.17 -0.15
Stochastic Oscillator 48.05 48.08

Price Performance

Historical Comparison
TECX
ELA

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. It operates through two segments, Consumer and Commercial Services. The Consumer segment, which generates key revenue for the company, predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins, and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

Share on Social Networks: